Is adolescent pertussis vaccination preferable to natural booster infections?

References

• Forsyth KD, Wirsing Von Konig CH, Tan T, Caro J, Plotkin S. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine25(14), 2634–2642 (2007).
   PubMed Web of Science ®Google Scholar
• Bisgard KM, Pascual FB, Ehresmann KR et al. Infant pertussis: who was the source? Pediatr. Infect. Dis. J.23(11), 985–989 (2004).
   PubMed Web of Science ®Google Scholar
• Lavine J, Broutin H, Harvill ET, Bjornstad ON. Imperfect vaccine-induced immunity and whooping cough transmission to infants. Vaccine29(1), 11–16 (2010).
   PubMedGoogle Scholar
• Kuehn BM. Panel backs wider pertussis vaccination to curb outbreaks, prevent deaths. JAMA304(24), 2684–2686 (2010).
   Google Scholar
• Hallander HO, Andersson M, Gustafsson L, Ljungman M, Netterlid E. Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program. APMIS117(12), 912–922 (2009).
   PubMed Web of Science ®Google Scholar
• Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr. Infect. Dis. J.24(5 Suppl.), S58–S61 (2005).
   PubMedGoogle Scholar
• Carlsson RM, Trollfors B. Control of pertussis – lessons learnt from a 10-year surveillance programme in Sweden. Vaccine27(42), 5709–5718 (2009).
   PubMedGoogle Scholar
• Hallander HO, Ljungman M, Storsaeter J, Gustafsson L. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children. APMIS117(11), 797–807 (2009).
   PubMed Web of Science ®Google Scholar
• Zepp F, Heininger U, Mertsola J et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect. Dis.11(7), 557–570 (2011).
   PubMed Web of Science ®Google Scholar
• De Greeff SC, Mooi FR, Schellekens JF, De Melker HE. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. Pediatr. Infect. Dis. J.27(3), 218–223 (2008).
   PubMed Web of Science ®Google Scholar
• Kandola K, Lea A, White W, Santos M. A comparison of pertussis rates in the Northwest Territories: pre- and postacellular pertussis vaccine introduction in children and adolescents. Can. J. Infect. Dis. Med. Microbiol.16(5), 271–274 (2005).
   PubMedGoogle Scholar
• Skowronski DM, De Serres G, Macdonald D et al. The changing age and seasonal profile of pertussis in Canada. J. Infect. Dis.185(10), 1448–1453 (2002).
   PubMed Web of Science ®Google Scholar
• Van Rie A, Hethcote HW. Adolescent and adult pertussis vaccination: computer simulations of five new strategies. Vaccine22(23–24), 3154–3165 (2004).
   PubMed Web of Science ®Google Scholar
• De Vries R, Kretzschmar M, Schellekens JF et al. Cost–effectiveness of adolescent pertussis vaccination for The Netherlands: using an individual-based dynamic model. PLoS One5(10), e13392 (2010).
   PubMed Web of Science ®Google Scholar
• Lee GM, Lett S, Schauer S et al. Societal costs and morbidity of pertussis in adolescents and adults. Clin. Infect. Dis.39(11), 1572–1580 (2004).
   PubMed Web of Science ®Google Scholar
• Jardine A, Conaty SJ, Lowbridge C, Staff M, Vally H. Who gives pertussis to infants? Source of infection for laboratory confirmed cases less than 12 months of age during an epidemic, Sydney, 2009. Commun. Dis. Intell.34(2), 116–121 (2010).
   PubMedGoogle Scholar
• Wendelboe AM, Njamkepo E, Bourillon A et al. Transmission of Bordetella pertussis to young infants. Pediatr. Infect. Dis. J.26(4), 293–299 (2007).
   PubMed Web of Science ®Google Scholar
• Preziosi MP, Halloran ME. Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness. Vaccine21(17–18), 1853–1861 (2003).
   PubMed Web of Science ®Google Scholar
• Trollfors B, Taranger J, Lagergard T et al. Immunization of children with pertussis toxoid decreases spread of pertussis within the family. Pediatr. Infect. Dis. J.17(3), 196–199 (1998).
   Google Scholar
• Rohani P, Zhong X, King AA. Contact network structure explains the changing epidemiology of pertussis. Science330(6006), 982–985 (2010).
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Detora LM, Johnson DR. An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine. Expert Rev. Vaccines5(2), 175–187 (2006).
   PubMed Web of Science ®Google Scholar
• Hethcote HW, Horby P, Mcintyre P. Using computer simulations to compare pertussis vaccination strategies in Australia. Vaccine22(17–18), 2181–2191 (2004).
   PubMed Web of Science ®Google Scholar
• Purdy KW, Hay JW, Botteman MF, Ward JI. Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis. Clin. Infect. Dis.39(1), 20–28 (2004).
   PubMed Web of Science ®Google Scholar
• Lee GM, Lebaron C, Murphy TV, Lett S, Schauer S, Lieu TA. Pertussis in adolescents and adults: should we vaccinate? Pediatrics115(6), 1675–1684 (2005).
   PubMed Web of Science ®Google Scholar
• De Greeff SC, Lugner AK, Van Den Heuvel DM, Mooi FR, De Melker HE. Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies. Vaccine27(13), 1932–1937 (2009).
   PubMed Web of Science ®Google Scholar
• Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev.18(2), 326–382 (2005).
   PubMed Web of Science ®Google Scholar
• Van Gent M, De Greeff SC, Van Der Heide HG, Mooi FR. An investigation into the cause of the 1983 whooping cough epidemic in The Netherlands. Vaccine27(13), 1898–1903 (2009).
   Google Scholar
• Hallander HO, Lepp T, Ljungman M, Netterlid E, Andersson M. Do we need a booster of Hib vaccine after primary vaccination? A study on anti-Hib seroprevalence in Sweden 5 and 15 years after the introduction of universal Hib vaccination related to notifications of invasive disease. APMIS118(11), 878–887 (2010).
   PubMed Web of Science ®Google Scholar
• Knuf M, Schmitt HJ, Wolter J et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J. Pediatr.152(5), 655–660, 660.e1 (2008).
   PubMed Web of Science ®Google Scholar
• Healy CM, Rench MA, Baker CJ.Implementation of cocooning against pertussis in a high-risk population. Clin. Infect. Dis.52(2), 157–162 (2011).
   PubMedGoogle Scholar
• Mooi FR, De Greeff SC. The case for maternal vaccination against pertussis. Lancet Infect. Dis.7(9), 614–624 (2007).
   PubMed Web of Science ®Google Scholar
• Mielcarek N, Debrie AS, Raze D et al. Attenuated Bordetella pertussis: new live vaccines for intranasal immunisation. Vaccine24(Suppl. 2), 54–55 (2006).
   Google Scholar
• Zhang L, Prietsch SO, Axelsson I, Halperin SA. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst. Rev.1, CD001478 (2011).
   Google Scholar